Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 21.

Jefferies, Matthew, Cox, Adam, Shorning, Boris, Meniel, Valerie, Griffiths, David, Kynaston, Howard, Smalley, Matthew and Clarke, Alan R. 2017. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis. Journal of Pathology 243 (4) , pp. 442-456. 10.1002/path.4977
filefilefilefilefile

Campbell, Lee, Jasani, Bharat, Griffiths, David Francis Rees and Gumbleton, Mark 2016. Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma. American Journal of Cancer Research 5 (9) , pp. 2838-2848.
file

Yang, Jian, Kalogerou, M, Samsel, Paulina, Zhang, Y., Griffiths, David, Gallacher, John, Sampson, Julian and Shen, Ming 2015. Renal tumours in a Tsc2+/- mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin. Oncogene 34 , pp. 922-931. 10.1038/onc.2014.17
file

Campbell, Lee, Aljayyoussi, Ghaith, Gutteridge, Robert, Gumbleton, Nigel, Griffiths, Rosie, Gumbleton, Simon, Smith, Mathew W., Griffiths, David Francis Rees and Gumbleton, Mark 2013. Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease. Journal of Translational Medicine 11 (1) , 255. 10.1186/1479-5876-11-255
file

Shorning, Boris, Griffiths, David Francis Rees and Clarke, Alan Richard 2011. Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder. PLoS ONE 6 (1) , e16209. 10.1371/journal.pone.0016209
file

Searchfield, Lydia, Price, Sally, Betton, Graham, Jasani, Bharat, Riccardi, Daniela and Griffiths, David Francis Rees 2011. Glutathione S-transferases as molecular markers of tumour progression and prognosis in renal cell carcinoma. Histopathology 58 (2) , pp. 180-190. 10.1111/j.1365-2559.2010.03733.x

Carrington, Christopher Peter, Williams, Aled, Griffiths, David Francis, Riley, Stephen George and Donovan, Kieron 2011. Adult day-case renal biopsy: a single-centre experience. Nephrology Dialysis Transplantation 26 (5) , pp. 1559-1563. 10.1093/ndt/gfq571

Chandra, Ashish, Griffiths, David Francis Rees and McWilliam, Lorna J. 2010. Best practice: gross examination and sampling of surgical specimens from the urinary bladder. Journal of Clinical Pathology 63 (6) , pp. 475-479. 10.1136/jcp.2009.071191

Campbell, L., Nuttall, R., Griffiths, David Francis Rees and Gumbleton, Mark 2009. Activated Extracellular Signal-Regulated Kinase Is an Independent Prognostic Factor in Clinically Confined Renal Cell Carcinoma. Cancer 115 (15) , pp. 3457-3467. 10.1002/cncr.24389

Campbell, Lee, Jasani, Bharat, Edwards, K., Gumbleton, Mark and Griffiths, David Francis Rees 2008. Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma. British Journal of Cancer 98 (5) , pp. 931-940. 10.1038/sj.bjc.6604243

Sansom, Owen J., Griffiths, David Francis Rees, Reed, Karen Ruth, Winton, Douglas J. and Clarke, Alan Richard 2005. Apc deficiency predisposes to renal carcinoma in the mouse. Oncogene 24 , pp. 8205-8210. 10.1038/sj.onc.1208956

Wilson, Catherine Helen, Idziaszczyk, Shelley Alexis, Parry, Lee, Guy, Carol, Griffiths, David Francis Rees, Lazda, Edgar Janis, Bayne, Rosemary A. L., Smith, Andrew J. H., Sampson, Julian Roy and Cheadle, Jeremy Peter 2005. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma. Human Molecular Genetics 14 (13) , pp. 1839-1850. 10.1093/hmg/ddi190

Dudderidge, Tim J., Stoeber, Kai, Loddo, Marco, Atkinson, Geraldine, Fanshawe, Thomas, Griffiths, David Francis Rees and Williams, Gareth H. 2005. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clinical cancer research 11 (7) , pp. 2510-2517. 10.1158/1078-0432.CCR-04-1776

Morris-Stiff, G., Steel, A., Savage, P., Devlin, J., Griffiths, David, Portman, B., Mason, Malcolm David and Jurewicz, W. A. 2004. Transmission of donor melanoma to multiple organ transplant recipients. American Journal of Transplantation 4 (3) , pp. 444-446. 10.1111/j.1600-6143.2004.00335.x

Campbell, Lee, Gumbleton, Mark and Griffiths, David Francis Rees 2003. Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma. British Journal of Cancer 89 (10) , pp. 1909-1913. 10.1038/sj.bjc.6601359

Hateboer, N., Gumbs, C., Teare, M. D., Coles, G. A., Griffiths, David Francis Rees, Ravine, D., Futreal, P. A. and Rahman, N. 2001. Confirmation of a gene locus for medullary cystic kidney disease (MCKD2) on chromosome 16p12. Kidney International 60 (4) , pp. 1233-1239. 10.1046/j.1523-1755.2001.00932.x

Gupta, S., Golash, A., Thomas, J. A., Cochlin, D., Griffiths, David Francis Rees and Jenkins, Brian J 2000. Epidermoid cysts of the testis: the case for conservative surgery. Annals of the Royal College of Surgeons of England 82 (6) , pp. 411-413.

Morris-Stiff, G., Griffiths, David Francis Rees, Jones, D., Quiroga, I., Baboo, R., Singh, J., Stockdill, H., Jones, G. V., Janezic, A., Baboolal, K. and Jurewicz, W. A. 1999. What is the true incidence of acute rejection (AR) in renal transplant recipients receiving calcineurin inhibitors? Transplantation 67 (9) , s547. 10.1097/00007890-199905150-00042

Barrington, J. W., Fulford, S., Griffiths, David Francis Rees and Stephenson, T. P. 1997. Tumors in bladder remnant after augmentation enterocystoplasty. The Journal of Urology 157 (2) , pp. 485-486. 10.1016/s0022-5347(01)65181-4

Thomas, J. A., Matanhelia, S. S., Griffiths, David Francis Rees and Matthews, P. N. 1994. Clitoral metastasis secondary to transitional cell carcinoma of the bladder. British Journal of Urology 74 (4) , pp. 524-525. 10.1111/j.1464-410x.1994.tb00441.x

Rooney, I. A., Davies, A., Griffiths, David Francis Rees, Williams, John David, Davies, M., Meri, S., Lachmann, P. J. and Morgan, B. P. 1991. The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells. Clinical and Experimental Immunology 83 (2) , pp. 251-256. 10.1111/j.1365-2249.1991.tb05623.x

This list was generated on Sat Sep 21 04:43:12 2019 BST.


Maintained by Cardiff University Information Services